Sunday, March 07, 2021 1:26:08 PM
“The panel considers that this drug is no longer a research priority and that resources should be used to evaluate other more promising drugs to prevent COVID-19,” the WHO said in a statement....
About time, wasted hospital patients lives and other possible treatment research...IMO
https://www.msn.com/en-us/health/medical/world-health-organization-advises-against-using-hydroxychloroquine-as-covid-19-treatment/ar-BB1eajPZ?ocid=msedgdhp
https://www.who.int/news-room/feature-stories/detail/who-recommends-against-the-use-of-remdesivir-in-covid-19-patients
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM